UBS Group AG - FOGHORN THERAPEUTICS INC ownership

FOGHORN THERAPEUTICS INC's ticker is FHTX and the CUSIP is 344174107. A total of 63 filers reported holding FOGHORN THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
UBS Group AG ownership history of FOGHORN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$52,180
-39.9%
10,436
-15.4%
0.00%
Q2 2023$86,810
+82.8%
12,331
+61.0%
0.00%
Q1 2023$47,486
+47.5%
7,659
+51.8%
0.00%
Q4 2022$32,200
-28.4%
5,047
+72.7%
0.00%
Q1 2022$45,000
-71.5%
2,923
-57.6%
0.00%
Q4 2021$158,000
+464.3%
6,893
+222.7%
0.00%
Q1 2021$28,000
-39.1%
2,136
-5.0%
0.00%
Q4 2020$46,0002,2480.00%
Other shareholders
FOGHORN THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Euclidean Capital LLC 1,261,261$17,153,00014.59%
Flagship Pioneering Inc. 12,674,120$172,368,0006.49%
Birchview Capital, LP 284,843$3,874,0002.82%
Artal Group S.A. 1,720,720$23,402,0001.25%
Alphabet Inc. 500,901$6,812,0000.37%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 777,525$10,574,0000.22%
DRIEHAUS CAPITAL MANAGEMENT LLC 382,940$5,208,0000.08%
XTX Topco Ltd 11,436$156,0000.06%
Virtus ETF Advisers LLC 8,198$111,0000.04%
Dynamic Technology Lab Private Ltd 20,551$279,0000.03%
View complete list of FOGHORN THERAPEUTICS INC shareholders